Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 118, Issue 11, Pages 1464-1475
Publisher
Springer Nature
Online
2018-05-10
DOI
10.1038/s41416-018-0110-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of long-term endothelial-barrier integrity is conditional to the cross-talk between Akt and Src signaling
- (2017) Fei Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy
- (2017) Vincent Chung et al. JAMA Oncology
- Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms
- (2016) Qi Wang et al. CANCER CELL
- AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
- (2016) Chia-Wei Li et al. CANCER RESEARCH
- Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover
- (2016) Fei Gao et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
- (2015) Ramesh K. Ramanathan et al. CANCER
- New insights in the control of vascular permeability
- (2015) Marianna Trani et al. CURRENT OPINION IN HEMATOLOGY
- Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion
- (2015) Harika Sabbineni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer
- (2015) Khanh Do et al. INVESTIGATIONAL NEW DRUGS
- Glycogen synthase kinase 3 in Wnt signaling pathway and cancer
- (2015) Nydia Tejeda-Muñoz et al. IUBMB LIFE
- Broad targeting of angiogenesis for cancer prevention and therapy
- (2015) Zongwei Wang et al. SEMINARS IN CANCER BIOLOGY
- Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia
- (2014) M. Y. Konopleva et al. CLINICAL CANCER RESEARCH
- Akt1 Mediates α-Smooth Muscle Actin Expression and Myofibroblast Differentiation via Myocardin and Serum Response Factor
- (2013) Maha Abdalla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis
- (2013) Belal AL-Husein et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor Endothelial Cells
- (2013) A. C. Dudley Cold Spring Harbor Perspectives in Medicine
- P21 Activated Kinase-1 (Pak1) Promotes Prostate Tumor Growth and Microinvasion via Inhibition of Transforming Growth Factor β Expression and Enhanced Matrix Metalloproteinase 9 Secretion
- (2012) Anna Goc et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The -Catenin Destruction Complex
- (2012) J. L. Stamos et al. Cold Spring Harbor Perspectives in Biology
- Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression
- (2010) S. T. Kochuparambil et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Akt-Mediated Transactivation of the S1P 1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids
- (2009) Patrick A. Singleton et al. CIRCULATION RESEARCH
- The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt
- (2009) P R Somanath et al. ONCOGENE
- MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells
- (2009) D. Iliopoulos et al. Science Signaling
- Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia
- (2008) Julie Gavard et al. DEVELOPMENTAL CELL
- The role of adherens junctions and VE-cadherin in the control of vascular permeability
- (2008) E. Dejana et al. JOURNAL OF CELL SCIENCE
- VE-cadherin and claudin-5: it takes two to tango
- (2008) Julie Gavard et al. NATURE CELL BIOLOGY
- Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5
- (2008) Andrea Taddei et al. NATURE CELL BIOLOGY
- Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability
- (2008) Christopher A Jones et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More